Differences in oncogenic potency but not target cell specificity distinguish the two forms of the BCR/ABL oncogene.

Two forms of activated BCR/ABL proteins, P210 and P185, that differ in BCR-derived sequences, are associated with Philadelphia chromosome-positive leukemias. One of these diseases is chronic myelogenous leukemia, an indolent disease arising in hematopoietic stem cells that is almost always associate...

תיאור מלא

מידע ביבליוגרפי

הוצא לאור ב:	Mol Cell Biol
Principais autores:	Kelliher, M, Knott, A, McLaughlin, J, Witte, O N, Rosenberg, N
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	Taylor & Francis 1991
נושאים:	Research Article
גישה מקוונת:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC361365/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/1875948/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/mcb.11.9.4710-4716.1991
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!